• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含亲脂性烷基碳链的青蒿素衍生物的合成及细胞毒性研究

Synthesis and cytotoxicity studies of artemisinin derivatives containing lipophilic alkyl carbon chains.

作者信息

Liu Yungen, Wong Vincent Kam-Wai, Ko Ben Chi-Bun, Wong Man-Kin, Che Chi-Ming

机构信息

Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China.

出版信息

Org Lett. 2005 Apr 14;7(8):1561-4. doi: 10.1021/ol050230o.

DOI:10.1021/ol050230o
PMID:15816752
Abstract

[reaction: see text] Cytotoxic artemisinin derivatives have been synthesized by a modular approach of "artemisinin + linker + lipophilic alkyl carbon chain". A strong correlation between the length of the carbon chains and the cytotoxicities against human hepatocellular carcinoma (HepG2) was revealed. Notably, compared with artemisinin (IC(50) = 97 microM), up to 200-fold more potent cytotoxicity (IC(50) = 0.46 microM) could be achieved by attachment of a C(14)H(29) carbon chain to artemisinin via an amide linker.

摘要

[反应:见正文] 细胞毒性青蒿素衍生物已通过“青蒿素+连接基+亲脂性烷基碳链”的模块化方法合成。揭示了碳链长度与对人肝癌细胞(HepG2)的细胞毒性之间的强相关性。值得注意的是,与青蒿素(IC50 = 97 μM)相比,通过酰胺连接基将C14H29碳链连接到青蒿素上可实现高达200倍的更强细胞毒性(IC50 = 0.46 μM)。

相似文献

1
Synthesis and cytotoxicity studies of artemisinin derivatives containing lipophilic alkyl carbon chains.含亲脂性烷基碳链的青蒿素衍生物的合成及细胞毒性研究
Org Lett. 2005 Apr 14;7(8):1561-4. doi: 10.1021/ol050230o.
2
Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction.金(III)双水杨醛缩乙二胺配合物催化通过三组分偶联反应合成炔丙胺。
Org Lett. 2006 Apr 13;8(8):1529-32. doi: 10.1021/ol0528641.
3
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle.靶向细胞周期G1期的新型抗肿瘤青蒿素衍生物。
Bioorg Med Chem Lett. 2001 Jan 8;11(1):5-8. doi: 10.1016/s0960-894x(00)00578-3.
4
C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene.C-16青蒿素衍生物及其抗疟和细胞毒性活性:通过对青蒿烯进行亲核加成合成青蒿素单体、二聚体、三聚体和四聚体
J Med Chem. 2001 Dec 20;44(26):4688-95. doi: 10.1021/jm0103007.
5
Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.新型脱氧青蒿素单体、二聚体和三聚体的抗肿瘤活性。
J Med Chem. 2003 Mar 13;46(6):987-94. doi: 10.1021/jm020119d.
6
NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.新型抗肿瘤候选药物双氢青蒿素和羧丙基双氢青蒿素的核磁共振研究
Biochem Biophys Res Commun. 2000 Aug 2;274(2):359-69. doi: 10.1006/bbrc.2000.3086.
7
Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.新型螺双环青蒿素类似物(青蒿素类似物):合成与抗肿瘤活性
Eur J Med Chem. 2015 Oct 20;103:17-28. doi: 10.1016/j.ejmech.2015.08.035. Epub 2015 Aug 18.
8
Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.青蒿素衍生的、化学性质稳定的三氧杂环乙烷二聚体的抗疟、抗增殖和抗肿瘤活性。
J Med Chem. 1999 Oct 21;42(21):4275-80. doi: 10.1021/jm990363d.
9
Synthesis of new artemisinin-derived dimers by self-cross-metathesis reaction.通过自交叉复分解反应合成新型青蒿素衍生二聚体。
Org Lett. 2005 Nov 10;7(23):5219-22. doi: 10.1021/ol052056+.
10
Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.合成具有潜在抗癌活性的新型青蒿素二聚体系列,涉及 Sonogashira 交叉偶联反应。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):237-9. doi: 10.1016/j.bmcl.2013.11.032. Epub 2013 Nov 23.

引用本文的文献

1
Chemo-proteomics in antimalarial target identification and engagement.抗疟药物靶标鉴定和结合的化学生物组学。
Med Res Rev. 2023 Nov;43(6):2303-2351. doi: 10.1002/med.21975. Epub 2023 May 26.
2
Comparative cytotoxicity and binding investigation of artemisinin and its biogenetic precursors with ctDNA.青蒿素及其生物合成前体与ctDNA的细胞毒性比较及结合研究。
RSC Adv. 2020 Jun 25;10(41):24203-24214. doi: 10.1039/d0ra02042g. eCollection 2020 Jun 24.
3
Targeting oncogenic Notch signaling with SERCA inhibitors.针对致癌性 Notch 信号通路的 SERCA 抑制剂。
J Hematol Oncol. 2021 Jan 6;14(1):8. doi: 10.1186/s13045-020-01015-9.
4
Antitumor Research on Artemisinin and Its Bioactive Derivatives.青蒿素及其生物活性衍生物的抗肿瘤研究
Nat Prod Bioprospect. 2018 Aug;8(4):303-319. doi: 10.1007/s13659-018-0162-1. Epub 2018 Apr 9.
5
Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7.基于青蒿素活性的探针可识别恶性疟原虫3D7无性阶段内的多个分子靶点。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2080-5. doi: 10.1073/pnas.1600459113. Epub 2016 Feb 8.
6
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.血红素激活青蒿素对恶性疟原虫的混杂靶向作用。
Nat Commun. 2015 Dec 22;6:10111. doi: 10.1038/ncomms10111.
7
A QSAR, pharmacokinetic and toxicological study of new artemisinin compounds with anticancer activity.具有抗癌活性的新型青蒿素化合物的定量构效关系、药代动力学及毒理学研究
Molecules. 2014 Jul 24;19(8):10670-97. doi: 10.3390/molecules190810670.
8
Development of artemisinin compounds for cancer treatment.青蒿素类化合物在癌症治疗方面的发展。
Invest New Drugs. 2013 Feb;31(1):230-46. doi: 10.1007/s10637-012-9873-z. Epub 2012 Aug 31.
9
A piperidine chiron for the Veratrum alkaloids.一种用于藜芦生物碱的哌啶型手性固定相。
J Org Chem. 2012 May 4;77(9):4235-41. doi: 10.1021/jo2026228. Epub 2012 Apr 13.
10
Functionalisation of artemisinin and its ring-contracted derivatives.青蒿素及其环缩合衍生物的功能化
Molecules. 2007 Mar 9;12(3):395-405. doi: 10.3390/12030395.